Complex role of zinc in methamphetamine toxicity in vitro

Neuroscience

Volumn 171, Issue 1, 2010, Pages 31-39

  Aizenman, E ^a   McCord, M C ^a   Saadi, R A ^a   Hartnett, K A ^a   He, K ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

Methamphetamine; Microglia; Potassium currents; Purinergic receptor; Toxicity; Zinc

Indexed keywords

CHELATING AGENT; METALLOTHIONEIN III; METHAMPHETAMINE; N,N,N',N' TETRAKIS(2 PYRIDYLMETHYL)ETHYLENEDIAMINE; TRICINE; UNCLASSIFIED DRUG; VOLTAGE GATED POTASSIUM CHANNEL; ZINC ION;

ANIMAL CELL; ARTICLE; CELL DAMAGE; CELL DEATH; COCULTURE; CONTROLLED STUDY; DRUG MECHANISM; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; IN VITRO STUDY; MICROGLIA; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANALYSIS OF VARIANCE; ANIMALS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ETHYLENEDIAMINES; GENE EXPRESSION REGULATION; GLYCINE; GREEN FLUORESCENT PROTEINS; MEMBRANE POTENTIALS; METHAMPHETAMINE; MICROGLIA; NERVE TISSUE PROTEINS; PATCH-CLAMP TECHNIQUES; PC12 CELLS; RATS; TRACE ELEMENTS; TRANSFECTION; ZINC;

EID: 77957870952     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.08.049     Document Type: Article

References (53)

1. Aizenman E., Stout A.K., Hartnett K.A., Dineley K.E., McLaughlin B., Reynolds I.J. Induction of neuronal apoptosis by thiol oxidation: putative role of intracellular zinc release. J Neurochem 2000, 75:1878-1888.
2. Ajjimaporn A., Phansuwan-Pujito P., Ebadi M., Govitrapong P. Zinc protects SK-N-SH cells from methamphetamine-induced alpha-synuclein expression. Neurosci Lett 2007, 419:59-63.
3. Ajjimaporn A., Swinscoe J., Shavali S., Govitrapong P., Ebadi M. Metallothionein provides zinc-mediated protective effects against methamphetamine toxicity in SK-n_SH cells. Brain Res Bull 2005, 67:466-475.
4. Aras M.A., Hara H., Hartnett K.A., Kandler K., Aizenman E. PKC regulation of neuronal zinc signaling mediates survival during preconditioning. J Neurochem 2009, 110:106-117.
5. Aras M.A., Hartnett K.A., Aizenman E. Assessment of cell viability in primary neuronal cultures. Curr Protoc Neurosci- Chapter 7 2008, Unit 7.18.
6. 2+ regulates Kv2.1 voltage-dependent gating and localization following ischemia. Eur J Neurosci 2009, 30:2250-2257.
7. Boeckman F.A., Aizenman E. Pharmacological properties of acquired excitotoxicity in Chinese hamster ovary cells transfected with N-methyl-d-aspartate receptor subunits. J Pharmacol Exp Ther 1996, 279:515-523.
8. Cadet J.L., Ordonez S.V., Ordonez J.V. Methamphetamine induces apotosis in immortalized neural cells: protection by the proto-oncogene, bcl-2. Synapse 1997, 25:176-184.
9. Chang L., Alicata D., Ernst T., Volkow N. Structural and metabolic brain changes in the striatum associated with methamphetamine abuse. Addiction 2007, 102(Suppl 1):16-32.
10. Cheepsunthorn P., Radov L., Menzies S., Reid J., Connor J.R. Characterization of a novel brain-derived microglial cell line isolated from neonatal rat brain. Glia 2001, 35:53-62.
11. Chen X., Zhang B., Harmon P.M., Schaffner W., Peterson D.O., Giedroc D.P. A novel cysteine cluster in human metal-responsive transcription factor 1 is required for heavy metal-induced transcriptional activation in vivo. J Biol Chem 2004, 279:4515-4522.
12. Chung R.S., Hidalgo J., West A.K. New insight into the molecular pathways of metallothionein-mediated neuroprotection and regeneration. J Neurochem 2008, 104:14-20.
13. Coddou C., Codocedo J.F., Li S., Lillo J.G., Acuña-Castillo C., Bull P., Stojilkovic S.S., Huidobro-Toro J.P. Reactive oxygen species potentiate the P2X2 receptor activity through Intracellular Cys430. J Neurosci 2009, 29:12284-12291.
14. Colton C.A., Gilbert D.L. Production of superoxide anions by a CNS macrophage, the microglia. FEBS Lett 1987, 223:284-288.
15. Cubells J.F., Rayport S., Rajendran G., Sulzer D. Methamphetamine neurotoxicity involves vacuolation of endocytic organelles and dopamine-dependent intracellular oxidative stress. J Neurosci 1994, 14:2260-2271.
16. Dietz R.M., Weiss J.H., Shuttleworth C.W. Contributions of Ca2+ and Zn2+ to spreading depression-like events and neuronal injury. J Neurochem 2009, 109(Suppl 1):145-152.
17. Du S., McLaughlin B., Pal S., Aizenman E. In vitro neurotoxicity of methylisothiazolinone, a commonly used industrial and household biocide, proceeds via a zinc and extracellular signal-regulated kinase mitogen-activated protein kinase-dependent pathway. J Neurosci 2002, 22:7408-7416.
18. Fabbro A., Skorinkin A., Gandolfo M., Nistri A., Giniatullin R. Quantal release of ATP from clusters of PC12 cells. J Physiol 2004, 15:505-517.
19. Franke H., Schepper C., Illes P., Krügel U. Involvement of P2X and P2Y receptors in microglial activation in vivo. Purinergic Signal 2007, 3:435-445.
20. Guilarte T.R., Nihei M.K., McGlothan J.L., Howard A.S. Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity. Neuroscience 2003, 122:499-513.
21. Hara H., Aizenman E. A molecular technique for detecting the liberation of intracellular zinc in cultured neurons. J Neurosci Methods 2004, 137:175-180.
22. Hughes F.M., Cidlowski J.A. Potassium is a critical regulator of apoptotic enzymes in vitro and in vivo. Adv Enzyme Regul 1999, 39:157-171.
23. Jayanthi S., Deng X., Bordelon M., McCoy M.T., Cadet J.L. Methamphetamine causes differential regulation of pro-death and anti-death Bcl-2 genes in the mouse neocortex. FASEB J 2001, 15:1745-1752.
24. Jayanthi S., Deng X., Ladenheim B., McCoy M.T., Cluster A., Cai N.S., Cadet J.L. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Proc Natl Acad Sci U S A 2005, 102:868-873.
25. Jayanthi S., Deng X., Noailles P.A., Ladenheim B., Cadet J.L. Methamphetamine induces neuronal apoptosis via cross-talk between endoplasmic reticulum and mitochondria-dependent death cascades. FASEB J 2004, 18:238-251.
26. Kauppinen T.M., Higashi Y., Suh S.W., Escartin C., Nagasawa K., Swanson R.A. Zinc triggers microglial activation. J Neurosci 2008, 28:5827-5835.
27. Knoch M.E., Hartnett K.A., Hara H., Kandler K., Aizenman E. Microglia induce neurotoxicity via intraneuronal Zn(2+) release and a K(+) current surge. Glia 2008, 56:89-96.
28. Krasnova I.N., Cadet J.L. Methamphetamine toxicity and messengers of death. Brain Res Rev 2009, 60:379-407.
29. LaVoie M.J., Card J.P., Hastings T.G. Microglial activation precedes dopamine terminal pathology in methamphetamine-induced neurotoxicity. Exp Neurol 2004, 187:47-57.
30. Maret W. Metallothionein redox biology in the cytoprotective and cytotoxic functions of zinc. Exp Gerontol 2008, 43:378-381.
31. McLaughlin B., Pal S., Tran M.P., Parsons A.A., Barone F.C., Erhardt J.A., Aizenman E. p38 activation is required upstream of potassium current enhancement and caspase cleavage in thiol oxidant-induced neuronal apoptosis. J Neurosci 2001, 21:3303-3311.
32. Pal S., He K., Aizenman E. Nitrosative stress and potassium channel-mediated neuronal apoptosis: is zinc the link?. Pflugers Arch 2004, 448:296-303.
33. Palmiter R.D. Regulation of metallothionein genes by heavy metals appears to be mediated by a zinc-sensitive inhibitor that interacts with a constitutively active transcription factor, MTF-1. Proc Natl Acad Sci U S A 1994, 91:1219-1223.
34. Paoletti P., Ascher P., Neyton J. High-affinity zinc inhibition of NMDA NR1-NR2A receptors. J Neurosci 1997, 17:5711-5725.
35. Redman P.T., Hartnett K.A., Aras M.A., Levitan E.S., Aizenman E. Regulation of apoptotic potassium currents by coordinated zinc-dependent signalling. J Physiol 2009, 587:4393-4404.
36. Redman P.T., He K., Hartnett K.A., Jefferson B.S., Hu L., Rosenberg P.A., Levitan E.S., Aizenman E. Apoptotic surge of potassium currents is mediated by p38 phosphorylation of Kv2.1. Proc Natl Acad Sci U S A 2007, 104:3568-3573.
37. Sekine Y., Ouchi Y., Sugihara G., Takei N., Yoshikawa E., Nakamura K., Iwata Y., Tsuchiya K.J., Suda S., Suzuki K., Kawai M., Takebayashi K., Yamamoto S., Matsuzaki H., Ueki T., Mori N., Gold M.S., Cadet J.L. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 2008, 28:5756-5761.
38. Sensi S.L., Paoletti P., Bush A.I., Sekler I. Zinc in the physiology and pathology of the CNS. Nat Rev Neurosci 2009, 10:780-791.
39. Thomas D.M., Dowgiert J., Geddes T.J., Francescutti-Verbeem D., Liu X., Kuhn D.M. Microglial activation is a pharmacological specific marker for the neurotoxic amphetamines. Neurosci Lett 2004, 367:349-354.
40. Thomas D.M., Francesutti-Verbeem D.M., Kuhn D.M. The newly synthesized pool of dopamine determines the severity of methamphetamine-induced neurotoxicity. J Neurochem 2007, 105:605-616.
41. Thomas D.M., Francesutti-Verbeem D.M., Liu X., Kuhn D.M. Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J Pharmacol Exp Ther 2004, 311:1-7.
42. Thomas D.M., Kuhn D.M. MK-801 and dextromethorphan block microglial activation and protection against methamphetamine-induced toxicity. Brain Res 2005, 1050:190-198.
43. Thomas D.M., Kuhn D.M. Cyclooxygenase-2 is an obligatory factor in methamphetamine-induced neurotoxicity. J Pharmacol Exp Ther 2005, 313:870-876.
44. Thompson P.M., Hayashi K.M., Simon S.L., Geaga J.A., Hong M.S., Sui Y., Lee J.Y., Toga A.W., Ling W., London E.D. Structural abnormalities in the brains of human subjects who methamphetamine. J Neurosci 2004, 24:6028-6036.
45. van der Veen R.C., Hinton D.R., Incardonna F., Hofman F.M. Extensive peroxynitrite activity during progressive stages of central nervous system inflammation. J Neuroimmunol 1997, 77:1-7.
46. West A.K., Hidalgo J., Eddins D., Levin E.D., Aschner M. Metallothionein in the central nervous system: roles in protection, regeneration and cognition. Neurotoxicology 2008, 29:489-503.
47. Winslow B.T., Voorhees K.I., Pehl K.A. Methamphetamine abuse. Am Fam Physician 2007, 76:1169-1174.
48. Yamamoto B.K., Bankson M.G. Amphetamine neurotoxicity: cause and consequence of oxidative stress. Crit Rev Neurobiol 2005, 17:87-117.
49. Yamamoto B.K., Moszczynska A., Gudelsky G.A. Amphetamine toxicities. Ann N Y Acad Sci 2010, 1187:101-121.
50. Yoshimoto S., Ouchi Y., Sugihara G., Takei N., Yoshikawa E., Nakamura K., Iwata Y., Tsuchiya K.J., Suda S., Suzuki K., Kawai M., Takebayashi K., Yamamoto S., Matsuzaki H., Ueki T., Mori N., Gold M.S., Cadet J.L. Methamphetamine causes microglial activation in the brains of human abusers. J Neurosci 2008, 28:5756-5761.
51. Yu S.P. Regulation and critical role of potassium homeostasis in apoptosis. Prog Neurobiol 2003, 70:363-386.
52. 2 in vitro is modulated by metallothionein. Mol Cell Biol 2003, 23:8471-8485.
53. Zhang L., Kitaichi K., Fujimoto Y., Nakayama H., Shimizu E., Iyo M., Hashimoto K. Protective effects of minocycline on behavioral changes and neurotoxicity in mice alter administration of methamphetamine. Prog Neuropsychopharmacol Biol Psychiatry 2006, 30:1381-1393.